PDF
Episurf: Episealer® Knee technology and clinical results to be presented at European congress
Episurf Medical (Nasdaq: EPIS B) today announces that the Episealer® Knee technology and clinical results are being presented at the 5[th] International Conference on Meniscus Science and Surgery (Luxembourg, July 7-9, 2022). The presentation is held by Prof Karl Eriksson from Stockholm South Hospital and The Karolinska Institute, Stockholm, Sweden. The presentation will focus on the expected clinical outcome after resurfacing of cartilage defects in the knee, and the latest results from an ongoing European multicentre study will be presented as a part of the presentation.
"The segment which we are focusing on, patients in the gap age who are too old for biological treatment alternatives and too young for knee replacements, has become an established topic for discussion on the scientific meetings. The delegates at this meeting, having a focus on knee joint preservation, is a highly important group of surgeons and we are proud that our technology will be presented as a part of the scientific program", says Pål Ryfors, CEO, Episurf Medical.